NO892270L - Fremgangsmaate for fremstilling av preparater for anvendelse ved behandlingen av alkoholisme. - Google Patents

Fremgangsmaate for fremstilling av preparater for anvendelse ved behandlingen av alkoholisme.

Info

Publication number
NO892270L
NO892270L NO89892270A NO892270A NO892270L NO 892270 L NO892270 L NO 892270L NO 89892270 A NO89892270 A NO 89892270A NO 892270 A NO892270 A NO 892270A NO 892270 L NO892270 L NO 892270L
Authority
NO
Norway
Prior art keywords
alcoholism
preparations
procedure
preparation
treatment
Prior art date
Application number
NO89892270A
Other languages
English (en)
Norwegian (no)
Other versions
NO892270D0 (no
Inventor
Gian Luigi Gessa
Fabio Fadda
Chiara Mormile Di Campochiaro
Original Assignee
Lab Farmaceutico C T Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lab Farmaceutico C T Srl filed Critical Lab Farmaceutico C T Srl
Publication of NO892270D0 publication Critical patent/NO892270D0/no
Publication of NO892270L publication Critical patent/NO892270L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO89892270A 1988-06-03 1989-06-02 Fremgangsmaate for fremstilling av preparater for anvendelse ved behandlingen av alkoholisme. NO892270L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT20859/88A IT1217783B (it) 1988-06-03 1988-06-03 Impiego di salo dell,acido gamma idrossi butirrico per la preparazione di composizioni farmaceutiche adatta ad essereimpiegate nella terapia dell,alcolismo e composizioni relative

Publications (2)

Publication Number Publication Date
NO892270D0 NO892270D0 (no) 1989-06-02
NO892270L true NO892270L (no) 1989-12-04

Family

ID=11173141

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89892270A NO892270L (no) 1988-06-03 1989-06-02 Fremgangsmaate for fremstilling av preparater for anvendelse ved behandlingen av alkoholisme.

Country Status (16)

Country Link
US (1) US4983632A (de)
EP (1) EP0344704B1 (de)
AR (1) AR241512A1 (de)
AT (1) ATE126433T1 (de)
AU (1) AU633002B2 (de)
CA (1) CA1330423C (de)
DE (1) DE68923819T2 (de)
DK (1) DK174017B1 (de)
ES (1) ES2075011T3 (de)
FI (1) FI892718L (de)
GR (1) GR3018009T3 (de)
IT (1) IT1217783B (de)
NO (1) NO892270L (de)
NZ (1) NZ229399A (de)
PT (1) PT90732B (de)
ZA (1) ZA894128B (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5153219A (en) * 1991-04-22 1992-10-06 Morris D. Faiman Thiocarbamate sulfoxide composition for deterring ethanol ingestion
IT1248588B (it) * 1991-06-28 1995-01-19 Gaetano Crepaldi Composizioni farmaceutiche per la terapia dell'astinenza, del " craving", della dipendenza da sostanze stupefacenti, da sostanze psicoattive, da nicotina e dei disturbi alimentari.
WO1993002682A1 (en) * 1991-08-06 1993-02-18 Labco Pharmaceuticals, Inc. Method and compositions for reducing craving for alcohol and stimulants
US5366990A (en) * 1991-11-14 1994-11-22 Reid Larry D Method for treating alcohol abuse and alcoholism
IT1261432B (it) * 1993-03-26 1996-05-23 Sigma Tau Ind Farmaceuti Uso di acil l- carnitina gammaidrossibutirrato per il trattamento dell'alcolismo.
IT1261485B (it) * 1993-06-24 1996-05-23 Sigma Tau Ind Farmaceuti Uso di acil l-carnitine gamma-idrossibutirrato per il trattamento di tossicodipendenze.
IT1266565B1 (it) * 1993-07-22 1997-01-09 Ct Lab Farm Srl Composizioni farmaceutiche a rilascio controllato a base di uno o piu' sali farmaceuticamente accettabili dell'acido gamma-idrossi-butirrico.
IT1283782B1 (it) * 1996-08-09 1998-04-30 Ct Lab Farm Srl Uso di ammidi dell'acido gamma-idrossibutirrico nel trattamento di tossicodipendenze,ed in particolare sell'alcolismo
CA2355293C (en) 1998-12-23 2005-08-16 Orphan Medical, Inc. Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
EP1316309A1 (de) * 1998-12-23 2003-06-04 Orphan Medical Inc. Mikrobenbeständige und stabilisierte Lösungen die gamma-Hydroxybuttersäuresalze zur Behandlung von Narkolepsie enthalten
JP5031144B2 (ja) 1999-03-25 2012-09-19 メタボリックス，インコーポレイテッド ポリヒドロキシアルカノエートポリマーの医療デバイスおよび医療適用
WO2001019361A2 (en) * 1999-09-14 2001-03-22 Tepha, Inc. Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate
ITMI20020754A1 (it) * 2002-04-09 2003-10-09 Aboca S P A Composizioni effervescenti contenenti succhi di frutta essicati
RU2210360C1 (ru) * 2002-09-19 2003-08-20 Общество С Ограниченной Ответственностью "Консорциум-Пик" Психотропное средство
ES2527857T3 (es) 2003-05-08 2015-01-30 Tepha, Inc. Tejidos y fibras médicas de polihidroxialcanoato
PT1778305E (pt) 2004-08-03 2010-07-27 Tepha Inc Suturas de poli-hidroxialcanoato que n†o se enrolam
US7838556B2 (en) * 2006-02-21 2010-11-23 University Of Maryland, Baltimore Ethers of 3-hydroxyphenylacetic acid as selective gamma-hydroxybutyric acid receptor ligands
EP2073812A4 (de) * 2006-09-29 2012-08-08 Univ Illinois Histonacetyl-transferase-aktivatoren und histonacetyl-deacetylase-hemmer bei der behandlung von alkoholismus
US7943683B2 (en) 2006-12-01 2011-05-17 Tepha, Inc. Medical devices containing oriented films of poly-4-hydroxybutyrate and copolymers
US8778398B2 (en) 2008-11-04 2014-07-15 Jazz Pharmaceuticals, Inc. Immediate release formulations and dosage forms of gamma-hydroxybutyrate
US8771735B2 (en) 2008-11-04 2014-07-08 Jazz Pharmaceuticals, Inc. Immediate release dosage forms of sodium oxybate
FR2938431B1 (fr) * 2008-11-14 2013-12-20 Debregeas Et Associes Pharma Nouvelle composition a base d'acide gamma-hydroxybutyrique
FR2949062B1 (fr) 2009-08-12 2011-09-02 Debregeas Et Associes Pharma Nouvelles formulations pharmaceutiques contre le mesusage des medicaments
FR2949061B1 (fr) 2009-08-12 2013-04-19 Debregeas Et Associes Pharma Microgranules flottants
CA2794171C (en) 2010-03-24 2018-07-03 Jazz Pharmaceuticals, Inc. Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
EP2566462B1 (de) * 2010-05-04 2020-07-08 Jazz Pharmaceuticals Inc. Formulierungen mit unmittelbarer freisetzung und darreichungsformen von gamma-hydroxybutyrat
US8591922B1 (en) 2012-12-14 2013-11-26 Jazz Pharmacuticals, Inc. Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
US9050302B2 (en) 2013-03-01 2015-06-09 Jazz Pharmaceuticals Ireland Limited Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
EP3180040B1 (de) 2014-08-15 2020-05-13 Tepha, Inc. Selbsthaltendes chirurgisches nahtmaterial aus poly-4-hydroxybutyrat und copolymeren davon
US10626521B2 (en) 2014-12-11 2020-04-21 Tepha, Inc. Methods of manufacturing mesh sutures from poly-4-hydroxybutyrate and copolymers thereof
WO2016094669A1 (en) 2014-12-11 2016-06-16 Tepha, Inc. Methods of orienting multifilament yarn and monofilaments of poly-4-hydroxybutyrate and copolymers thereof
US10398662B1 (en) 2015-02-18 2019-09-03 Jazz Pharma Ireland Limited GHB formulation and method for its manufacture
US11986451B1 (en) 2016-07-22 2024-05-21 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
UY37341A (es) 2016-07-22 2017-11-30 Flamel Ireland Ltd Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada
US11602512B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11504347B1 (en) 2016-07-22 2022-11-22 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602513B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US12186296B1 (en) 2016-07-22 2025-01-07 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US12478604B1 (en) 2016-07-22 2025-11-25 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US20180263936A1 (en) 2017-03-17 2018-09-20 Jazz Pharmaceuticals Ireland Limited Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
CA3115122A1 (en) 2018-11-19 2020-05-28 Jazz Pharmaceuticals Ireland Limited Alcohol-resistant drug formulations
EP3930702A1 (de) 2019-03-01 2022-01-05 Flamel Ireland Limited Gamma-hydroxybutyratzusammensetzungen mit verbesserter pharmakokinetik im zugeführten zustand
TW202139986A (zh) 2020-02-21 2021-11-01 愛爾蘭商爵士製藥愛爾蘭有限責任公司 治療原發性嗜睡症之方法
WO2022076824A1 (en) 2020-10-08 2022-04-14 Jazz Pharmaceuticals Ireland Limited Sodium oxybate to treat idiopathic hypersomnia
US11583510B1 (en) 2022-02-07 2023-02-21 Flamel Ireland Limited Methods of administering gamma hydroxybutyrate formulations after a high-fat meal
US11779557B1 (en) 2022-02-07 2023-10-10 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
JP2026513019A (ja) 2023-02-03 2026-04-22 トリス・フアルマ・インコーポレーテツド １晩１回の低ナトリウムオキシベート組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0044801B1 (de) * 1980-07-17 1984-02-15 Josef Dr. Klosa Nichthygroskopische Salze der 4-Hydroxybuttersäure, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Mittel

Also Published As

Publication number Publication date
FI892718A7 (fi) 1989-12-04
EP0344704A1 (de) 1989-12-06
NO892270D0 (no) 1989-06-02
DE68923819T2 (de) 1996-01-18
FI892718A0 (fi) 1989-06-02
FI892718L (fi) 1989-12-04
US4983632A (en) 1991-01-08
ZA894128B (en) 1990-03-28
ATE126433T1 (de) 1995-09-15
PT90732A (pt) 1989-12-29
IT1217783B (it) 1990-03-30
PT90732B (pt) 1994-10-31
CA1330423C (en) 1994-06-28
EP0344704B1 (de) 1995-08-16
IT8820859A0 (it) 1988-06-03
DK272389A (da) 1989-12-04
AR241512A1 (es) 1992-08-31
NZ229399A (en) 1997-02-24
DK174017B1 (da) 2002-04-15
ES2075011T3 (es) 1995-10-01
DK272389D0 (da) 1989-06-02
AU3590489A (en) 1989-12-07
AU633002B2 (en) 1993-01-21
GR3018009T3 (en) 1996-02-29
DE68923819D1 (de) 1995-09-21

Similar Documents

Publication Publication Date Title
NO892270D0 (no) Fremgangsmaate for fremstilling av preparater for anvendelse ved behandlingen av alkoholisme.
NO875045D0 (no) Fremgangsmaate for fremstilling av topiske preparater for behandling av akne.
NO900613D0 (no) Fremgangsmaate for fremstilling av aktiverte chitosaner oganvendelse ved fremstilling av chitosanderivater.
NO180362C (no) Fremgangsmåte for fremstilling av cyklosporinholdige preparater
NO872966L (no) Fremgangsmaate for fremstilling av granulocyttstimulerende preparater.
NO872712D0 (no) Fremgangsmaate for fremstilling av kalsiumholdige preparater.
NO902003L (no) Fremgangsmaate for fremstilling av n-heteroaryl-4-quinolinaminer.
NO166032C (no) Fremgangsmaate ved fremstilling av triklormonosilan.
NO894210D0 (no) Fremgangsmaate for fremstilling av kinolyloxazol-2-oner.
NO901554D0 (no) Fremgangsmaate for fremstilling av dinatrium-cefodizim.
NO894649D0 (no) Fremgangsmaate for fremstilling av (s)-alfa-ethyl-2-oxo-1-pyrrolidinacetamid.
NO893329D0 (no) Fremgangsmaate for fremstilling av titanoksyd.
NO895032L (no) Fremgangsmaate for fremstilling av 2-benzotiazoliner.
NO890159D0 (no) Fremgangsmaate for fremstilling av 1-alkyl-5-nitroimidazoler.
NO893794L (no) Fremgangsmaate for fremstilling av forbedret hydrolysert protein.
IT8821300A0 (it) Procedimento di preparazione di morniflumato e analoghi.
NO903347D0 (no) Fremgangsmaate for fremstilling av 14,17alfa-ethano- og ethanooestratriener.
NO900969L (no) Fremgangsmaate for fremstilling av n-allymetatrifluormetylanilin.
NO901067D0 (no) Fremgangsmaate for fremstilling av tiofener.
NO905543D0 (no) Fremgangsmaate for fremstilling og anvendelse av aminopyridinylmetanoler og aminometylpyridinaminer.
NO895040D0 (no) Fremgangsmaate for fremstilling av polyhydroxybenzyloxypropanolaminer.
NO893796L (no) Fremgangsmaate for fremstilling av forbedret hydrolysert protein.
NO912279L (no) Fremgangsmaate for fremstilling og anvendelse av eksplosjonssikre 1-dimetylamino-3-dimetylimino-2-arylprop-1-en-salter.
NO893795D0 (no) Fremgangsmaate for fremstilling av forbedret hydrolysert protein.
NO171107C (no) Mellomprodukt til anvendelse ved fremstilling av di-t-butylfenyl-alkyl- og fenyletere